Constronics Infra Limited (BOM:523844)
44.93
+3.73 (9.05%)
At close: Nov 16, 2026
Constronics Infra Revenue
Constronics Infra had revenue of 107.94M INR in the quarter ending September 30, 2026, a decrease of -45.14%. This brings the company's total for the last twelve months to 358.09M, down -46.32% year-over-year. In the fiscal year ending March 31, 2026, Constronics Infra had annual revenue of 486.14M, down -4.63%. That makes Constronics Infra the 40,834th largest company in the world by revenue and 4,029th in India.
Revenue (ttm)
358.09M
Revenue Growth
-46.32%
P/S Ratio
1.44
Revenue / Employee
14.92M
Employees
24
Market Cap
562.93M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 486.14M | -23.60M | -4.63% |
| Mar 31, 2025 | 509.75M | 502.02M | 6,498.64% |
| Mar 31, 2024 | 7.73M | -483.00K | -5.88% |
| Mar 31, 2023 | 8.21M | -13.52M | -62.22% |
| Mar 31, 2022 | 21.72M | 6.46M | 42.32% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.62B |
| Chandra Bhagat Pharma | 1.74B |
| Novelix Pharmaceuticals | 1.55B |
| VijayPD Ceutical | 1.00B |
| Medico Intercontinental | 864.77M |
| Medistep Healthcare | 731.36M |
| Zenlabs Ethica | 485.60M |
| Goldline Pharmaceutical | 311.98M |